All Stories

  1. Smaller clinical trials for decision making; using p-values could be costly
  2. A systematic review and critical analysis of cost-effectiveness studies for coronary artery disease treatment
  3. A case study of the Vitamin C sepsis bundle: Opportunity costs of delayed adoption
  4. A systematic review and critical analysis of cost-effectiveness studies for coronary artery disease treatment
  5. An economic analysis of the benefits of sterilizing medical instruments in low-temperature systems instead of steam
  6. Time to publication for publicly funded clinical trials in Australia: an observational study
  7. What is a hospital bed day worth? A contingent valuation study of hospital Chief Executive Officers
  8. Effectiveness of the cardiac-diabetes transcare program: protocol for a randomised controlled trial
  9. CHERISH (collaboration for hospitalised elders reducing the impact of stays in hospital): protocol for a multi-site improvement program to reduce geriatric syndromes in older inpatients
  10. Characteristics of national and statewide health care–associated infection surveillance programs: A qualitative study
  11. Economic evaluation of fecal microbiota transplantation for the treatment of recurrentClostridium difficileinfection in Australia
  12. Is it worth screening elective orthopaedic patients for carriage ofStaphylococcus aureus? A part-retrospective case–control study in a Scottish hospital
  13. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae andStaphylococcus aureusin European hospitals, 2010 and 2011: a multicentre retrospective cohort study
  14. A cost-effectiveness modelling study of strategies to reduce risk of infection following primary hip replacement based on a systematic review
  15. Reasons doctors provide futile treatment at the end of life: a qualitative study
  16. What does “futility” mean? An empirical study of doctors’ perceptions
  17. Novel application of a discrete choice experiment to identify preferences for a national healthcare-associated infection surveillance programme: a cross-sectional study
  18. Cost-Effectiveness of a National Initiative to Improve Hand Hygiene Compliance Using the Outcome of Healthcare Associated Staphylococcus aureus Bacteraemia
  19. Change to costs and lengths of stay in the emergency department and the Brisbane protocol: an observational study
  20. The role of time pressure and different psychological safety climate referents in the prediction of nurses’ hand hygiene compliance
  21. A randomized trial of fellowships for early career researchers finds a high reliability in funding decisions
  22. Improved wound management at lower cost: a sensible goal for Australia
  23. Researching effective approaches to cleaning in hospitals: protocol of the REACH study, a multi-site stepped-wedge randomised trial
  24. Understanding the determinants of Australian hospital nurses' hand hygiene decisions following the implementation of a national hand hygiene initiative
  25. Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease
  26. The need for cost-effectiveness analyses of antimicrobial stewardship programmes: A structured review
  27. Comparative efficacy of interventions to promote hand hygiene in hospital: systematic review and network meta-analysis
  28. Differences in identifying healthcare associated infections using clinical vignettes and the influence of respondent characteristics: a cross-sectional survey of Australian infection prevention staff
  29. Using simplified peer review processes to fund research: a prospective study
  30. Variation in health care-associated infection surveillance practices in Australia
  31. The Magnitude of Time-Dependent Bias in the Estimation of Excess Length of Stay Attributable to Healthcare-Associated Infections
  32. Allied health growth: what we do not measure we cannot manage
  33. Cost and outcomes of assessing patients with chest pain in an Australian emergency department
  34. The cost-effectiveness of the MobileMums intervention to increase physical activity among mothers with young children: a Markov model informed by a randomised controlled trial
  35. Key beliefs of hospital nurses’ hand-hygiene behaviour: protecting your peers and needing effective reminders
  36. The Impact of Healthcare-Associated Methicillin-Resistant Staphylococcus Aureus Infections on Post-Discharge Healthcare Costs and Utilization
  37. Using a theory of planned behaviour framework to explore hand hygiene beliefs at the ‘5 critical moments’ among Australian hospital-based nurses
  38. Cost-effectiveness analysis of a hospital electronic medication management system
  39. Streamlined research funding using short proposals and accelerated peer review: an observational study
  40. Intravascular device administration sets: replacement after standard versus prolonged use in hospitalised patients--a study protocol for a randomised controlled trial (The RSVP Trial)
  41. Response to Grayson's Letter to the Editor: ‘Response to K. Page et al., ‘Costing the Australian National Hand Hygiene Initiative’’
  42. The impact of a streamlined funding application process on application time: two cross-sectional surveys of Australian researchers
  43. Randomized Controlled Trial of an Improved Version of MobileMums, an Intervention for Increasing Physical Activity in Women with Young Children
  44. Healthcare-associated infections in Australia: time for national surveillance
  45. Opportunity cost of unavailable surgical instruments in Australian hospitals
  46. Changes in healthcare-associated infections after the introduction of a national hand hygiene initiative
  47. Costing the Australian National Hand Hygiene Initiative
  48. Bridging the Gap: Exploring the Barriers to Using Economic Evidence in Healthcare Decision Making and Strategies for Improving Uptake
  49. Valuation of Hospital Bed-Days Released by Infection Control Programs: A Comparison of Methods
  50. The return to work experiences of middle-aged Australian workers diagnosed with colorectal cancer: a matched cohort study
  51. Depression in Working Adults: Comparing the Costs and Health Outcomes of Working When Ill
  52. Changes in Healthcare-Associated Staphylococcus aureus Bloodstream Infections after the Introduction of a National Hand Hygiene Initiative
  53. How costs change with infection prevention efforts
  54. Living Well With Diabetes: 24-Month Outcomes From a Randomized Trial of Telephone-Delivered Weight Loss and Physical Activity Intervention to Improve Glycemic Control
  55. Control strategies to prevent total hip replacement-related infections: a systematic review and mixed treatment comparison
  56. The economics of UTI surveillance
  57. The impact of funding deadlines on personal workloads, stress and family relationships: a qualitative study of Australian researchers
  58. The prolongation of length of stay because of Clostridium difficile infection
  59. Educational interventions for preventing vascular catheter bloodstream infections in critical care: evidence map, systematic review and economic evaluation
  60. Are educational interventions to prevent catheter-related bloodstream infections in intensive care unit cost-effective?
  61. Scholarly writing, peer-review and quality papers for Healthcare Infection
  62. Student and supervisor productivity change during nutrition and dietetic practice placements: A cohort study
  63. Moving forward with hospital cleaning
  64. The increased risks of death and extra lengths of hospital and ICU stay from hospital-acquired bloodstream infections: a case–control study
  65. Surgical site infection prevention following total hip arthroplasty in Australia: A cost-effectiveness analysis
  66. Humans, ‘things’ and space: costing hospital infection control interventions
  67. Post-discharge surgical site surveillance – where to from here?
  68. Moving MobileMums forward: protocol for a larger randomized controlled trial of an improved physical activity program for women with young children
  69. Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression
  70. Linking Scientific Evidence and Decision Making A Case Study of Hand Hygiene Interventions
  71. Surgical treatment approaches and reimbursement costs of surgical site infections post hip arthroplasty in Australia: a retrospective analysis
  72. Australia's grant system wastes time
  73. Most relevant strategies for preventing surgical site infection after total hip arthroplasty: Guideline recommendations and expert opinion
  74. Long-term survival after intensive care unit discharge in Thailand: a retrospective study
  75. On the time spent preparing grant proposals: an observational study of Australian researchers
  76. The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer
  77. Key priorities for Australian infection control: summary of findings from the launch of the Centre for Research Excellence in Reducing Healthcare Associated Infections
  78. Cost effectiveness of nutrition support in the prevention of pressure ulcer in hospitals
  79. Productivity and Time Use during Occupational Therapy and Nutrition/Dietetics Clinical Education: A Cohort Study
  80. Evaluating the economics of the Australian National Hand Hygiene Initiative
  81. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol: Figure 1
  82. Development of an economic model to assess the cost-effectiveness of hawthorn extract as an adjunct treatment for heart failure in Australia
  83. Occupational therapy students’ contribution to occasions of service during practice placements in health settings
  84. Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation
  85. Funding grant proposals for scientific research: retrospective analysis of scores by members of grant review panel
  86. Open versus closed IV infusion systems: a state based model to predict risk of catheter associated blood stream infections
  87. Bureaucracy savings should go to research
  88. The Importance of Good Data, Analysis, and Interpretation for Showing the Economics of Reducing Healthcare-Associated Infection
  89. The Working After Cancer Study (WACS): a population-based study of middle-aged workers diagnosed with colorectal cancer and their return to work experiences
  90. The Time-Dependent Bias and its Effect on Extra Length of Stay due to Nosocomial Infection
  91. Time-dependent analysis of extra length of stay and mortality due to ventilator-associated pneumonia in intensive-care units of ten limited-resources countries: findings of the International Nosocomial Infection Control Consortium (INICC)
  92. Potential of St John's Wort for the Treatment of Depression: The Economic Perspective
  93. Time-dependent analysis of length of stay and mortality due to urinary tract infections in ten developing countries: INICC findings
  94. Cutting random funding decisions
  95. The use of economic evaluation in CAM: an introductory framework
  96. A policy case study of blood in Australia
  97. Excess Length of Stay Due to Central Line–Associated Bloodstream Infection in Intensive Care Units in Argentina, Brazil, and Mexico
  98. Cost-Effectiveness of a Central Venous Catheter Care Bundle
  99. Malnutrition and pressure ulcer risk in adults in Australian health care facilities
  100. Living Well with Diabetes: a randomized controlled trial of a telephone-delivered intervention for maintenance of weight loss, physical activity and glycaemic control in adults with type 2 diabetes
  101. Multiple Health Behavior Changes and Co-variation in a Telephone Counseling Trial
  102. Estimating the Cost of Health Care–Associated Infections: Mind Your p’s and q’s
  103. Obesity in pregnancy: outcomes and economics
  104. The costs arising from pressure ulcers attributable to malnutrition
  105. The Cost-effectiveness of Routine Follow-up After Primary Total Hip Arthroplasty
  106. Cost-Effectiveness of an Intervention to Reduce Emergency Re-Admissions to Hospital among Older Patients
  107. Cost-Effectiveness of a Telephone-Delivered Intervention for Physical Activity and Diet
  108. Using a Longitudinal Model to Estimate the Effect of Methicillin-resistant Staphylococcus aureus Infection on Length of Stay in an Intensive Care Unit
  109. Economic rationale for infection control in Australian hospitals
  110. Modeling Length of Stay in Hospital and Other Right Skewed Data: Comparison of Phase-Type, Gamma and Log-Normal Distributions
  111. Telephone Counseling for Physical Activity and Diet in Primary Care Patients
  112. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision
  113. Economics and Preventing Healthcare Acquired Infection
  114. Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants
  115. The International Nosocomial Infection Control Consortium (INICC): Goals and objectives, description of surveillance methods, and operational activities
  116. Nosocomial Infection, the Deficit Reduction Act, and Incentives for Hospitals
  117. Overcrowding and understaffing in modern health-care systems: key determinants in meticillin-resistant Staphylococcus aureus transmission
  118. Who bears the cost of healthcare-acquired surgical site infection?
  119. The Logan Healthy Living Program: A cluster randomized trial of a telephone-delivered physical activity and dietary behavior intervention for primary care patients with type 2 diabetes or hypertension from a socially disadvantaged community — Rationale...
  120. Catheter-related bloodstream infections in intensive care units: a systematic review with meta-analysis
  121. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units
  122. Competing risks models and time-dependent covariates
  123. Mental health in the workplace: Using the ICF to model the prospective associations between symptoms, activities, participation and environmental factors
  124. Factors associated with health care-acquired urinary tract infection
  125. Which presenteeism measures are more sensitive to depression and anxiety?
  126. A review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol
  127. Effect of Healthcare-Acquired Infection on Length of Hospital Stay and Cost
  128. Economics and Preventing Hospital-Acquired Infection: Broadening the Perspective
  129. Cost-effectiveness analyses and modelling the lifetime costs and benefits of health-behaviour interventions
  130. A Cost-effectiveness Analysis of Two Rehabilitation Support Services for Women with Breast Cancer
  131. Modeling the economic losses from pressure ulcers among hospitalized patients in Australia
  132. Effect of Pressure Ulcers on Length of Hospital Stay
  133. Correcting for bias when estimating the cost of hospital-acquired infection: an analysis of lower respiratory tract infections in non-surgical patients
  134. A comparison of competing methods for the detection of surgical-site infections in patients undergoing total arthroplasty of the knee, partial and total arthroplasty of hip and femoral or similar vascular bypass
  135. Would Universal Antenatal Screening for HIV Infection Be Cost‐Effective in a Setting of Very Low Prevalence? Modelling the Data for Australia
  136. Modeling the Costs of Hospital-Acquired Infections in New Zealand
  137. The cost effectiveness of universal antenatal screening for HIV in New Zealand
  138. The Prevalence and Estimates of the Cumulative Incidence of Hospital-Acquired Infections Among Patients Admitted to Auckland District Health Board Hospitals in New Zealand
  139. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods
  140. The epic project: developing national evidence-based guidelines for preventing healthcare associated infections
  141. The health economic implications of treatment with quetiapine: an audit of long-term treatment for patients with chronic schizophrenia
  142. Adverse events in British hospitals
  143. An economic model to assess the cost and benefits of the routine use of silver alloycoated urinary catheters to reduce the risk of urinary tract infections in catheterized patients
  144. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed